Product class:
|
Authorized package
|
Medicinal product class:
|
Veterinary medicine
|
Package code:
|
1212084
|
Name of medicinal product:
|
Advocate täpilahus suurtele kassidele
|
Active substances:
|
|
ATC code:
|
QP54AB81
|
Dosage form:
|
spot-on solution
|
Route of administration:
|
cutaneous use
|
Strengh:
|
10mg+100mg 1ml
|
Amount in package:
|
0.8ml 6TK
|
Legal status for supply*:
|
Subject to medicinal prescription
|
Class of active substance:
|
|
Additional information:
|
|
Indication:
|
For cats suffering from, or at risk from, mixed parasitic infections:
the treatment and prevention of flea infestation (Ctenocephalides felis),
the treatment of ear mite infestation (Otodectes cynotis),
the treatment of notoedric mange (Notoedres cati),
the treatment of the lungworm Eucoleus aerophilus (syn. Capillaria aerophila) (adults),
the prevention of lungworm disease (L3/L4 larvae of Aelurostrongylus abstrusus),
the treatment of the lungworm Aelurostrongylus abstrusus (adults),
the treatment of the lungworm Troglostrongylus brevior (adults),
the treatment of the eye worm Thelazia callipaeda (adults),
the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis),
the treatment of infections with gastrointestinal nematodes (L4 larvae, immature adults and
adults of Toxocara cati and Ancylostoma tubaeforme).
The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
For ferrets suffering from, or at risk from, mixed parasitic infections:
the treatment and prevention of flea infestation (Ctenocephalides felis),
the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis).
|
Safety features:
|
No
|
Summary of product characteristics (SPC):
|
|
Package information leaflet (PIL):
|
EST
|
Labelling:
|
|
Withdrawal time:
|
Ei rakendata.
|
Species:
|
kass
|
Last imported to Estonia:
|
Never imported to Estonia
|
Marketing authorization holder:
|
Elanco Animal Health GmbH
|
Marketing authorization number:
|
EU/2/03/039
|
Marketing authorization issued on:
|
April 2, 2003
|
Marketing authorization expires on:
|
Unlimited
|
Marketing authorization procedure type:
|
Centralised
|
Entry/Changing date:
March 27, 2024
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere